The Melanoma Research Alliance (MRA) is the largest private funder of melanoma research. Since its founding in 2007, MRA has committed $88 million in funding to advance our understanding of this disease. MRA funds projects in the areas of prevention, diagnosis, and treatment, with the majority of funding allocated for melanoma treatment.

The mission of the Melanoma Research Alliance is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.

Learn more:
Melanoma Research Alliance Website